Rabi Hanna - Cell & Gene therapy Doc

Multi-omic profiling reveals age-related immune dynamics in healthy adults - Nature This multi-omic longitudinal analysis of the healthy human peripheral immune system constructs the Human Immune Health Atlas and assembles data on immune cell composition and state changes w...

How immuniry change wuth age - age-dependent TH2 bias in CD4 T cells and CD8 T cells is broadly driven by reduction in T cell signalling strength over time

www.nature.com/articles/s41...

Grateful to our amazing @CleClinic_PHO team for shining so brightly at #LightTheNight 🌟 Your passion and advocacy bring hope to leukemia & lymphoma patients and families every day. Together, we’re lighting the path toward a cure. ❤️🕯️ #LLS #TeamClevelandClinic @bloodcancerunited.bsky.social

You want to feel good and 🤩👏… come to @velosano . Nothing feels as good as being with previous #ChildhoodCancer patients who are now #Survivors and #riding for the #Cure

Here we go ; safe ride to all #Riders @bikeVeloSano 25 miles. 🙏thank you so much for all you do to raise $ for #CancerResearch at @ClevelandClinic 💯 for the #Cure . Cancer impact goes beyond one patient , one family … it affects the community and together 💪 can make an impact

The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy TO THE EDITOR:

The impact of CMV reactivation on mortality after chimeric antigen receptor T-cell therapy url: ashpublications.org/bloodadvance...

Trike & Bike | VeloSano Kids can help fight pediatric cancer with Trike & Bike. Join community bike rides supporting Cleveland Clinic Children’s. 100% of funds go to research.

Join us on July 26 at the Cleveland Metroparks Zoo for a one-of-a-kind bike ride for kids ages 3–10 to raise funds for pediatric #cancer #research at @clevelandclinic.bsky.social
. www.velosano.org/trike-bike
www.velosano.org/trike-bike/

Atul Butte San Francisco, CA Obituary, American pediatrician and UCSF professor Atul Janardhan Butte Dies From Cancer - Pioneer Dr. Atul Janardhan Butte, San Francisco, CA Obituary, Death: The vibrant San Francisco and global scientific communities mourn the loss of Dr. Atul Janardhan Butte, 55, who passed away on June 13, 202...

This is sad news abd huge loss to #Medicine #Pediatric and #Science in general . May his menory be a blessing . pioneerpressobits.space/atul-butte-s...

Mentorship is a powerful way to give back in #PedsHemOnc. I am so honored to be among #mentors at the American society of pediatric hematology - oncology speedy mentorship supporting the next generation boosts career satisfaction, fosters personal growth & strengthens our field for the future.

Dr. Caitlyn Duffy from @stjude.bsky.social presented great talk at poem_group about Implementation science in leukemia
1- discussed the 17 year odessy - translation of discovery to delivery
2- EPIS implementation framework

So grateful to be invited to #POEM 4th Scientific Conference! Connecting with ped oncologists to improve care & access for kids with cancer has been truly inspiring. 👏🎉 Dr. rawad rihani and Dr. Gevory Tamamyan for fantastic reception to start #POEM2025 #PediatricOncology #CancerCare

Finding the Words: Talking Cancer with Children Little Health: A Cleveland Clinic Children’s Podcast · Episode

open.spotify.com/episode/4SnN...

The St. Baldrick's Foundation hosted a fundraising event for kids with cancer Sunday afternoon. St. Baldrick's Foundation foundation hosts head shaving event, raises money for kids with cancer

A heartfelt thank you to our incredible team at Cleveland Clinic Children’s for coming together in support of St. Baldrick’s Foundation. Your dedication, generosity, and passion for making a difference in the lives of children with cancer is truly inspiring
#StBaldricks
m.youtube.com/watch?v=azNy...

Thank you 👏 Dr. Jim Fernandez for organising great conference #PrimaryImmunodeficiency at @ClevelandClinic and great talk about #IVIG . It is amazing to see the use increase significantly.

Did you know it takes 8-9 months to make IVIG and it approximately collected from 15,000 donors

Great advice by Troy Torgerson about what to do when you have VUS “variable unknown significance “ at @clevelandclinic.bsky.social #PrimaryImmuneDeficiency symposium

Join us for the inaugural Updates in Primary Immunodeficiency CME symposium. This course provides an educational forum for faculty to deliver in-depth reviews of common and rare inborn errors of immunity (IEI), a group of more than 400 complex, chronic disorders.

Still time to join us at #UodateInPrimaryImmunodeficiency at @clevelandclinic.bsky.social endorsed by immune deficiency foundation

Very educational agenda and world renowned experts discussing diagnosis and management of different immune deficiencies

www.clevelandclinicmeded.com/live/courses...

Celebrating a Second Chance at Life Symposium
May 3 - 9, 2025
A week packed full of information, inspiration and community.

symposium.bmtinfonet.org

The fight against # ChildhhodCancer is not just medical challenge - it is calling - beyond medication to wholistic care
So proud of our music therapist 🎉👏 Emily Ervin @CleClinicKids for supporting kids - see picture below 👇 with one of our kids cutting her hair

So proud and inspired by our team : Preston , Katie and Stacey participating in @clevelandclinic.bsky.social #StBaldrick shave for the cure event
We are doing what we do to support kids & their families and organisations like St Baldrick so we can do research to find more cure and better therapies

So excited to welcome our #Pediatric residents at @clevelandclinic.bsky.social
To join all our care givers in our mission “Caring for life, researching for health, educating those who serve”

Study Reveals New Clues Into Childhood Cancer Survivors’ Increased Risk of Melanoma Childhood cancer survivors have a more than two-fold increased risk of developing melanoma during their lifetime, compared to the general population, as well as a two-fold increased risk of death asso...

Childhood cancer survivors have a more than two-fold increased risk of developing melanoma during their lifetime, compared to the general population, as well as a two-fold increased risk of death associated with a melanoma diagnosis consultqd.clevelandclinic.org/study-reveal...

Student Visionaries of the year

fotoshare.co/i/20j6sp6 so excited to celebrate the grand finale of #LLS

Urge Reauthorization of the Rare Pediatric Disease Priority Review Voucher Program Rare pediatric diseases are an area with extreme unmet need in our health care ecosystem. The challenges associated with rare diseases, such as small populations, unknown cause and/or course of the di...

The Pediatric Rare Disease Priority Review Voucher Program, incentivizing research peds rare diseases expired Dec/2025. Research for #ChildhoodCancer is affected . ask Congress to reauthorize the program by supporting the Give Kids a Chance Act of 2025 (H.R. 1262)
www.votervoice.net/mobile/Bioco...

Haploidentical Bone Marrow Transplantation for Sickle Cell Disease Related human leukocyte antigen (HLA)–haploidentical bone marrow transplantation (BMT) with posttransplant cyclophosphamide may be curative for sickle cell disease. However, graft failure, severe g...

so honored to be part of the team led by Dr. Adetola kassim #BMTCTN CTN1507 Haplo-HCT for patients with severe sickle cell disease;
- Of 42 Adult pts underwent haplo-HCT: 95% alive at 2 yrs, 88% are potentially cured at fraction of the cost of gene therapy
evidence.nejm.org/doi/pdf/10.1...

Great job 👏 👏 by Dr. Mark Walters @uscfb.bsky.social to present RUBY study sponsored @editasmed -Gene therapy for #SCD
- sustained normal hemoglobin and hgb F above >40%
- F cells >>99.3%
- pain free in 27/28 patients
- improved QOL

Cleveland Clinic works on breakthrough cancer vaccine, even as funding for pediatric research lags A 12-year-old Atlanta girl has turned to Cleveland researchers for treatment of her Ewing Sarcoma, and the hope a breakthrough vaccine is on the way.

Watch this incredible story and then ask me why i chose to be pediatric oncologist- A fight for survival 💪
These kids are inspiration
Our team of clinician and scientists working on #Tumor Vaccine for Ewing Sarcoma
www.wkyc.com/article/news... www.wkyc.com/article/news...

Cleveland Clinic Children’s on LinkedIn: 2024 was an incredible year of innovation for our Division of Pediatric… 2024 was an incredible year of innovation for our Division of Pediatric Hematology & Oncology! We’re proud to share some of our key accomplishments from the…

2024 was an incredible year of innovation for our Division of Pediatric Hematology & Oncology! We’re proud to share some of our key accomplishments from the past year:
www.linkedin.com/posts/clevel...

Eat, Sleep, Poop, Grow!

I enjoyed listening to tbe new @clevelandclinic.bsky.social podcast about pediatric health related topics “Little health” open.spotify.com/episode/2uKa...

Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemia - Leukemia Leukemia - Relationship between donor source, pre-transplant measurable residual disease, and outcome after allografting for adults with acute myeloid leukemia

Cord blood transplant was associated with less risk of relapse in MRD positive AML getting MAC regimen HCT. www.nature.com/articles/s41...

Single-cell multi-omics map of human fetal blood in Down syndrome - Nature Using single-cell and multi-omics data of fetal blood, a high-resolution molecular map of dysregulated haematopoiesis in Down syndrome is provided.

AR Marderstein et al showed increased mitochondrial mass & oxidative stress in #Downsyndrome led to mutations in regulatory regions genes in HSCs which explain increased #Leukemia in DS Single-cell multi-omics of human fetal blood in #Down Syndrome @nature.com
www.nature.com/articles/s41...

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma Studies show promising EFS, PFS, and OS at 3 to 8 years

Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma offer excellent cure and should be considered for selected patients to avoid long term side effects of high dose chemo / autologous transplant
www.medpagetoday.com/hematologyon...